I now have excellent data from the textbooks, PMC case series, and guidelines. Here is the comprehensive answer:
Congenital Complete Heart Block (CCHB) in Pregnancy - Maternal Problems
Congenital complete heart block (CCHB) is rare in pregnant women (incidence ~1:15,000 to 1:20,000 births), and a mother who has it herself (not her fetus) and is relatively asymptomatic with only mild vertigo represents a specific clinical scenario. Here is a structured breakdown of the problems she may face:
1. Physiological Conflict: Fixed Heart Rate vs. Pregnancy Demands
This is the core problem. Pregnancy causes a progressive rise in cardiac output of 30-50%, driven largely by an increase in heart rate. In CCHB, the ventricular rate is set by a slow escape rhythm (typically 40-60 bpm) - the heart cannot increase its rate in response to demand.
- The body compensates partly by increasing stroke volume, but this compensation has limits
- By the third trimester, when demands are highest, compensatory mechanisms can fail
- A previously asymptomatic woman can decompensate during pregnancy and develop symptomatic bradycardia or heart failure
- The vertigos she already has are a warning sign - these are likely due to low cardiac output states, and they will tend to worsen as pregnancy progresses
(Fuster and Hurst's The Heart, 15th Edition)
2. Worsening of Vertigo / Pre-syncope and Syncope
- The mild vertigos she currently has represent transient low-flow episodes (Adams-Stokes type)
- As cardiac demands increase in pregnancy, these episodes can worsen into frank syncope
- Syncopal attacks reported in up to 29% of pregnant women with CHB in one case series (Mandal et al., 21 patients)
- Syncope during pregnancy carries risk of falls, placental abruption, and fetal injury
3. Risk of Developing Heart Failure
- The fixed low heart rate means augmentation of cardiac output depends entirely on stroke volume
- Volume overload of pregnancy (blood volume increases ~1.5 L) combined with fixed rate can cause ventricular dilatation and eventual systolic dysfunction
- In women with particularly slow escape rates (<40 bpm), heart failure can occur even without structural disease
4. Peripartum Period - The Highest-Risk Phase
Labor and delivery dramatically increase cardiac demand:
- During contractions: auto-transfusion of 300-500 mL blood per contraction
- Valsalva maneuver during pushing: can further suppress an already-slow heart rate
- However - textbook data is somewhat reassuring: asymptomatic women with CCHB generally do not require temporary pacing even during labor and Valsalva, provided they are monitored carefully (Fuster and Hurst's The Heart, 15th Edition)
- The immediate postpartum period also carries risk due to sudden volume shifts
5. Need for Permanent Pacemaker Insertion During Pregnancy
- If she becomes symptomatic during pregnancy (worsening vertigo, frank syncope, heart failure), permanent pacemaker implantation becomes necessary
- This can be done safely during pregnancy using echocardiographic guidance to minimize or eliminate radiation exposure to the fetus
- Pacemakers can be placed safely, but the procedure itself carries procedural risk (pneumothorax, infection, lead dislodgement)
6. Fetal / Obstetric Complications
- Intrauterine growth restriction (IUGR): reported in up to 14% of pregnancies with maternal CHB (Mandal series) - likely due to reduced uteroplacental perfusion from low maternal cardiac output
- Oligohydramnios: reported in ~7%
- Preterm labor / delivery: up to 11%, sometimes driven by IUGR requiring early delivery
- Absent or reversed diastolic flow in umbilical vessels (indicating severe uteroplacental insufficiency) requiring preterm cesarean section has been reported
7. Drug-Related Hazards During Labor and Delivery
Several commonly used obstetric drugs are hazardous or contraindicated in CCHB:
| Drug | Reason for Caution |
|---|
| Labetalol (used for pre-eclampsia) | Beta-blockade can further suppress heart rate |
| Nifedipine (used for preterm labor tocolysis) | Can worsen AV block and hypotension |
| Fentanyl | Associated with bradycardia and asystole |
| Suxamethonium | Can provoke bradycardia or asystole |
| Magnesium sulfate | At high serum levels causes prolonged AV conduction or complete block; risk in tocolysis or eclampsia management |
Drugs to keep ready: Atropine and isoproterenol (to rescue from sudden heart rate fall); transcutaneous pacing standby is recommended for delivery.
8. Mode of Delivery and Anesthetic Challenges
- Vaginal delivery is generally safe if she is well-monitored and heart rate is adequate
- Cesarean section (if needed) carries anesthetic challenge: spinal anesthesia can cause hypotension, which in a woman already with low cardiac output is dangerous
- Both spinal and general anesthesia carry special considerations; management requires a multidisciplinary team (cardiologist + obstetrician + anesthesiologist)
- Transcutaneous pacing should be on standby during any delivery
9. Psychological Stress and Monitoring Burden
- She will require increased antenatal surveillance: frequent echocardiograms, 24-hour Holter monitoring, serial fetal growth scans
- The anxiety of close monitoring adds psychological burden
- She should ideally be managed at a tertiary center with maternal-fetal medicine and cardiac expertise
Summary of Risk Stratification
| Risk Factor | Impact in This Patient |
|---|
| Asymptomatic at baseline | Favorable - lower risk |
| Mild vertigo present | Caution - suggests borderline compensation |
| No structural heart disease | Favorable |
| No pacemaker | Watch closely - may need one |
| CCHB escape rate <40 bpm | Higher risk |
| CCHB escape rate 50-60 bpm | Lower risk |
Bottom line: Most women with asymptomatic CCHB complete pregnancy successfully without major complications, but the existing vertigo signals she is already at the edge of compensation. She needs multidisciplinary care, careful monitoring throughout pregnancy, avoidance of contraindicated drugs, and a plan for pacemaker insertion if she decompensates. Her fetus also needs serial growth scans given the IUGR risk.
Sources: Fuster and Hurst's The Heart, 15th Edition; Creasy & Resnik's Maternal-Fetal Medicine; Pregnancy with Complete Heart Block (PMC5080265); Cesarean Delivery in CCHB - Anaesthetic Challenges